Latest Industry News & Trends
Market Scope provides comprehensive coverage of the ophthalmic market. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with executives. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic industry newsletters.
Laser News
ViaLase Teams up with Moran Eye Center to Enhance Femto Laser Glaucoma Procedure
ViaLase of Aliso Viejo, California, reported Dec. 10 that it would partner with the John A. Moran Eye Center at the University of Utah to explore the effect of creating multiple channels in the tra...
Asia-Pacific Markets and Lens-Based Procedures Drive Refractive Surgery
Economic conditions continue to be cited as the reason for flat or declining laser-vision correction (LVC)surgery rates in some markets in 2024. However, a shift in refractive surgery types and hig...
CMS Cuts Ophthalmologists’ Procedure Fees, While Raising ASC, HOPD Facility Fees
The Centers for Medicare and Medicaid Services (CMS) published on Nov. 1 the final schedule of Medicare reimbursement fees for physicians in 2025. It also released its facility fee payments for ASC...
MACs Finalize Coverage for Standalone and Combo MIGS Procedures
Five Medicare administrative contractors have issued their final coverage policies for minimally invasive glaucoma surgery, or MIGS, along with more technical billing and coding documents. The poli...
Bausch + Lomb Acquires Elios Vision, Developer of Excimer Laser Trabeculostomy
Bausch + Lomb announced Dec. 11 that an affiliate had acquired Elios Vision, developer of the Elios excimer laser trabeculostomy procedure for glaucoma. No financial details were disclosed. Elios’ ...
Zeiss Gains US Approval for MEL 90 Excimer Laser
Carl Zeiss Meditec gained US FDA approval on Dec. 4 for its MEL 90 excimer laser, the next-generation iteration of its MEL 80 for LASIK surgery. The MEL 90’s US labeling is for correction of myopia...
MACs Finalize Coverage for Standalone and Combo MIGS Procedures
Five Medicare administrative contractors have issued their final coverage policies for minimally invasive glaucoma surgery, or MIGS, along with more technical billing and coding documents. The poli...
CMS Cuts Ophthalmologists’ Procedure Fees, While Raising ASC, HOPD Facility Fees
The Centers for Medicare and Medicaid Services (CMS) published on Nov. 1 the final schedule of Medicare reimbursement fees for physicians in 2025. It also released its facility fee payments for ASC...
Q3-2024 Ophthalmic Revenue Roundup for Immunocore, Harrow, Tarsus, Lumibird, and Ocular Therapeutix
UK-headquartered Immunocore reported Nov. 6 that its Q3-2024 net revenue from Kimmtrak (tebentafusp) was $80.2 million, a 28 percent increase over $62.6 million in Q3-2023. Regionally, Kimmtrak net...
Q3-2024 Ophthalmic Revenue Roundup for Alcon, Hoya, RxSight, Sight Sciences, and Iridex
Alcon reported Nov. 12 that its Q3-2024 net sales totaled $2.4 billion, a 6 percent increase over $2.3 billion in Q3-2023. Surgical net sales for implantables, consumables, and equipment/other were...
Q3-2024 Ophthalmic Revenue Roundup for AbbVie, Apellis, Glaukos, STAAR, and Lensar
AbbVie, of North Chicago, Illinois, reported Oct. 30 that its Q3-2024 eye care net revenue was $525 million, a 13.5 percent decline (-11.2 percent cc) from $605 million in Q3-2023. Restasis revenue...
Select US FDA Approvals and Clearances in September 2024
The US FDA granted two clearances through the ophthalmic device division using the 510(k) pathway in September 2024, according to the agency’s database. Zeiss gained clearance for its combination Y...
ViaLase Releases Latest Glaucoma Laser Data at ESCRS Congress
Rick Lewis, MD, chief medical officer at ViaLase, provided an update at the 2024 ESCRS congress on the ViaLuxe glaucoma laser, including the system’s most recent clinical trial results. The ViaLuxe...
October 2024 Ophthalmic News Briefs
Oculus has announced the addition of frequency doubling perimetry (FDP) to its Easyfield VR visual field diagnostic headset. The German ophthalmic diagnostic company, with US headquarters in Arling...
Iridex Appoints Patrick Mercer as Chief Executive Officer
Iridex reported Oct. 3 that it had appointed Patrick Mercer as chief executive officer, to go along with his role as president, effective Oct. 1. Mercer had also served as the company’s chief opera...
Lensar Ends Collaboration with Oertli for Phaco Portion of Ally Cataract System
Lensar has terminated its collaboration agreement with Swiss company Oertli, according to a filing Aug. 5 with the US Securities and Exchange Commission. The two had been developing the Ally Adapti...
MeiraGTx Leads Latest Ophthalmic Fundraising with $50 Million Offering
MeiraGTx led recent ophthalmic fundraising efforts with a $50 million offering of ordinary shares as it moves forward with its extensive pipeline of gene therapy candidates. Financing announced in ...
ViaLase Gains CE Marking for Femtosecond Laser for Glaucoma Treatment
ViaLase announced July 30 that the European Union had granted CE marking for its ViaLase Laser for the treatment of adults with primary open-angle glaucoma. The system uses an OCT-guided femtosecon...
Q2-2024 Ophthalmic Revenue Roundup for AbbVie, Carl Zeiss Meditec, Amgen, STAAR, Astellas, Immunocore, Tarsus, Biogen, Lensar, and Iridex
AbbVie, of North Chicago, Illinois, reported July 25 that Q2-2024 net revenue for its eye care products totaled $533 million, a 13.3 percent decline (-10.9 percent cc) from $617 million in Q2-2023....
ViaLase Gains CE Marking for Femtosecond Laser for Glaucoma Treatment
ViaLase announced July 30 that the European Union had granted CE marking for its ViaLase Laser for the treatment of adults with primary open-angle glaucoma. The system uses an OCT-guided femtosecon...
Q2-2024 Ophthalmic Revenue Roundup for Regeneron, Roche, Bausch + Lomb, Novartis, and Four Others
Regeneron, of Tarrytown, New York, reported Aug. 1 that its Q2-2024 US revenue for Eylea was $1.53 billion, a 2 percent increase from $1.5 billion in Q2-2023. Eylea HD accounted for $304 million of...
Q1-2024 Ophthalmic Revenue Roundup for AbbVie, Iridex, and Biogen
AbbVie, of North Chicago, Illinois, reported April 26 that its Q1-2024 eye care net revenue totaled $538 million, an 11.7 percent decline (-10.4 percent cc) from $608 million in Q1-2023. Restasis r...
Alcon to Acquire Glaucoma Laser Company Belkin Vision for up to $335M
Alcon is acquiring Israel’s Belkin Vision, maker of the Eagle laser for glaucoma, for up to $335 million, according to reports. The value of the transaction was first estimated in a story dated May...
Alcon to Acquire Glaucoma Laser Company Belkin Vision for up to $335 Million
Alcon is acquiring Israel’s Belkin Vision, maker of the Eagle laser for glaucoma, for up to $335 million, according to reports. The value of the transaction was first estimated in a story dated May...
Q1-2024 Ophthalmic Revenue Roundup for Bausch + Lomb, Glaukos, and Lumibird
Bausch + Lomb reported May 1 that its Q1-2024 revenue was $1.1 billion, an 18 percent increase (+20 percent cc) over $931 million in Q1-2023. Vision Care segment revenue in Q1-2024 was $635 million...
Outlook Leads Latest Ophthalmic Fundraising with $164M in Private Placements
Retinal drug developer Outlook Therapeutics led recent ophthalmic fundraising efforts with two private placements, for proceeds totaling $164 million. Financing announced in the past four weeks tot...
2023 Ophthalmic Revenue Roundup for Iridex and NovaBay
Iridex, of Mountain View, California, reported March 26 that its 2023 revenue was $51.9 million, a 9 percent decrease from $57 million in 2022. Cyclo G6 product revenue was $13.4 million, a 9 perce...
South Dakota Expands Optometrists’ Scope to Include SLT, YAG, Incisions
South Dakota Gov. Kristi Noem on March 4 signed into law a measure expanding the scope of practice of optometrists in the state. HB 1099 allows doctors of optometry to administer injections around ...
South Dakota Expands Optometrists’ Scope to Include SLT, YAG, Incisions
South Dakota Gov. Kristi Noem on March 4 signed into law a measure expanding the scope of practice of optometrists in the state. HB 1099 allows doctors of optometry to administer injections around ...
2023 Ophthalmic Revenue Roundup for Immunocore, RxSight, Lensar, and Biogen
UK-headquartered Immunocore reported Feb. 28 that its 2023 net product revenue from Kimmtrak (tebentafusp) was $238.7 million, a 70 percent increase over $140.7 million in 2022. The 2023 total was ...
Bausch + Lomb Teneo Excimer Laser Enters US Market After Drought in New Technology
A new excimer laser has entered the US refractive market for the first time in nearly two decades. Bausch + Lomb announced in January that the US FDA had approved the Teneo excimer laser platform f...
Select US FDA Approvals and Clearances in January 2024
The US FDA granted two clearances through the ophthalmic device division using the 510(k) pathway in January 2024, according to the agency’s database. Meridian received clearance for three laser mo...
Ace Vision Group Names Val Kolesnitchenko, MD, as Chief Scientific Officer
Ace Vision Group announced Feb. 13 that it had named Val Kolesnitchenko, MD, as chief scientific officer. Most recently, Kolesnitchenko held the position of executive director of global scientific ...
2023 Ophthalmic Revenue Roundup for Roche, Novartis, and Lumibird
Swiss company Roche reported Feb. 1 that global sales of Vabysmo for 2023 were CHF 2.36 billion ($2.78 billion, converted Feb. 1, 2024), a 299 percent increase (+324 percent cc) over CHF 591 millio...
Belkin Vision’s Eagle Laser for Glaucoma Receives FDA 510(k) Clearance
Israeli company Belkin Vision reported Dec. 12 that its Eagle laser for glaucoma had gained US FDA 510(k) clearance. The Eagle is intended for use in performing a new automated, noncontact, one-sec...
Carl Zeiss Meditec’s VisuMax 800 and SMILE Software Gain US FDA Approval
Carl Zeiss Meditec reported Jan. 11 that the US FDA had approved its updated VisuMax 800 femtosecond refractive laser and related SMILE software for surgically treating nearsightedness with or with...
Select US FDA Approvals and Clearances in December 2023
The US FDA granted five clearances through the ophthalmic device division using the 510(k) pathway in December 2023, according to the agency’s database. RetMap gained market clearance for its RM El...
January 2024 Ophthalmic News Briefs
Maker of Sophi Phaco Machines UK-based Rayner announced Jan. 17 that it had acquired Switzerland’s This AG, the maker of Sophi phacoemulsification machines. No financial details were disclosed. Sop...
New Iridex 532 and Iridex 577 Lasers Launched in US Market
Iridex announced Jan. 11 the US launch of its next-generation Iridex 532 green and Iridex 577 yellow lasers for retina and glaucoma. Iridex, of Mountain View, California, said both lasers include c...
Belkin Vision’s Eagle Laser Receives FDA 510(k) Clearance
Israeli company Belkin Vision reported Dec. 12 that its Eagle laser for glaucoma had gained US FDA 510(k) clearance. The Eagle is intended for use in performing a new automated, noncontact, one-sec...
Q3-2023 Ophthalmic Revenue Roundup for Alcon, Iridex, and Lensar
Alcon reported Nov. 14 that its Q3-2023 net sales totaled $2.3 billion, an 8 percent increase (+9 percent cc) over $2.1 billion in Q3-2022. Surgical net sales for implantables, consumables, and equ...
Select US FDA Approvals and Clearances in October 2023
The US FDA granted five clearances through the ophthalmic device division using the 510(k) pathway in October 2023, according to the agency’s database. Heidelberg gained market clearance for its An...
Q3-2023 Ophthalmic Revenue Roundup for Hoya, Lumibird, Sight Sciences, and Ocular Therapeutix
Japan-based Hoya Corporation reported Oct. 31 that its medical segment (IOLs, endoscopes, and artificial bone) generated revenue for the third quarter of 2023—its fiscal year Q2-2023—of ¥33.5 billi...
Ace Vision Group Names Rob Kissling, MD, as Chief Medical Officer
Laser company Ace Vision Group announced Nov. 1 that it had named Rob Kissling, MD, as chief medical officer. Most recently, Kissling served as vice president of clinical and medical affairs at Bau...
Select US FDA Approvals and Clearances in September 2023
The US FDA granted five clearances through the ophthalmic device division using the 510(k) pathway in September 2023, according to the agency’s database. CSO gained clearance for its MS-39 anterior...
Ophthalmic Laser Companies Look to Improve on Convenience, Experience
The therapeutic ophthalmic laser market will experience modest growth in the next five years, as laser manufacturers focus on improving convenience and experience for ophthalmologists and patients....
Laser Company Iridex to Undergo Strategic Review
Iridex announced Aug. 29 that it would undergo a review of strategic alternatives, with Piper Sandler acting as financial advisor. The Mountain View, California, ophthalmic laser company said there...
Iridex to Undergo Strategic Review
Iridex announced Aug. 29 that it would undergo a review of strategic alternatives, with Piper Sandler acting as financial advisor for the process. The Mountain View, California, ophthalmic laser co...
Q2-2023 Ophthalmic Revenue Roundup for Alcon, Immunocore, Harrow, and Two Others
Alcon reported Aug. 15 that its Q2-2023 net sales totaled $2.4 billion, a 9 percent increase (+12 percent cc) over $2.2 billion in Q2-2022. Surgical net sales for implantables, consumables, and equ...
Want to Read the Full Article?
Already Have an Account?
Register A Corporate Account
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.